| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.33▲ | 1.33▲ | 1.33▲ | 1.32▲ | 1.31▲ |
| MA10 | 1.33▲ | 1.33▲ | 1.33▲ | 1.32▲ | 1.29▲ |
| MA20 | 1.33▲ | 1.33▲ | 1.33▲ | 1.32▲ | 1.27▲ |
| MA50 | 1.30▲ | 1.30▲ | 1.30▲ | 1.30▲ | 1.41▼ |
| MA100 | 1.29▲ | 1.29▲ | 1.29▲ | 1.25▲ | 1.71▼ |
| MA200 | 1.28▲ | 1.27▲ | 1.28▲ | 1.34▼ | 2.79▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.000▼ | 0.000▲ | -0.002▼ | 0.027▲ |
| RSI | 57.582▲ | 57.300▲ | 57.088▲ | 52.590▲ | 50.769▲ |
| STOCH | 49.744 | 49.744 | 49.744 | 39.541 | 64.861 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -55.397 | -28.834 |
| CCI | 152.874▲ | 152.874▲ | 152.874▲ | 38.466 | 90.148 |
|
Tuesday, July 01, 2025 12:59 PM
LAVA Therapeutics NV (NASDAQ:LVTX) an immuno-oncology company focused on developing its proprietary Gammabody platform of... By Investing.com ...
|
|
Thursday, June 19, 2025 05:01 PM
The latest price target for LAVA Therapeutics (NASDAQ:LVTX) was reported by JMP Securities on May 15, 2025. The analyst firm set a price target for $0.00 expecting LVTX to fall to within 12 months ...
|
|
Monday, May 19, 2025 04:59 PM
LAVA Therapeutics (NASDAQ:LVTX – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for LAVA Therapeutics in a research note ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/07/25 | 1.30 | 1.34 | 1.30 | 1.32 | 3,996 |
| 02/07/25 | 1.37 | 1.38 | 1.30 | 1.31 | 19,864 |
| 01/07/25 | 1.32 | 1.35 | 1.31 | 1.32 | 20,027 |
| 30/06/25 | 1.31 | 1.32 | 1.29 | 1.32 | 13,057 |
| 27/06/25 | 1.31 | 1.33 | 1.29 | 1.31 | 11,959 |
| 26/06/25 | 1.27 | 1.31 | 1.27 | 1.305 | 7,744 |
| 25/06/25 | 1.33 | 1.33 | 1.29 | 1.3143 | 7,181 |
| 24/06/25 | 1.3312 | 1.3399 | 1.29 | 1.325 | 5,899 |
| 23/06/25 | 1.32 | 1.34 | 1.30 | 1.325 | 4,822 |
| 20/06/25 | 1.35 | 1.3821 | 1.30 | 1.31 | 15,523 |
|
|
||||
|
|
||||
|
|